1
|
Nonreferral of possible soft tissue sarcomas in adults: a dangerous omission in policy.
|
Sarcoma
|
2009
|
1.21
|
2
|
Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer.
|
Oncology
|
2003
|
1.01
|
3
|
Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer.
|
Am J Clin Oncol
|
2003
|
0.97
|
4
|
Long-term results after resection for bone sarcoma pulmonary metastases.
|
Eur J Cardiothorac Surg
|
2009
|
0.95
|
5
|
Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients.
|
J Immunol
|
2011
|
0.89
|
6
|
Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy.
|
Oncologist
|
2007
|
0.83
|
7
|
Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo.
|
Int J Cancer
|
2010
|
0.83
|
8
|
Clinical practice guidelines on antiemetics in oncology.
|
Expert Rev Anticancer Ther
|
2005
|
0.82
|
9
|
Activity of gefitinib in central nervous system metastases in patients with non-small-cell lung cancer: two case reports and a review of the literature.
|
Clin Lung Cancer
|
2005
|
0.78
|
10
|
Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer.
|
Am J Clin Oncol
|
2004
|
0.75
|